biotech news today obesity drugs glp-1 As an medicine physician, it is hard not to get excited about where the science is headed., This week, new phase 3 data on retatrutide showed average weight loss of over 28%, with some Weight loss with GLP-1 medicines

Claims of dramatic transformations and minimal risks don't align with what the published literature supports

Longevity-related laboratory research discussions

in men, usually around age 35

They concluded that glutathione supplementation may have a beneficial effect on lupus patients by reducing oxidative stress and inflammation

Since its discovery in 1977, DSIP has transitioned from being viewed strictly as a somnogenic (sleep-inducing) agent to a multifaceted neuromodulator with significant implications in neuroendocrinology and stress adaptation

Prioritize sleep (79 hours) and stress management to support adherence and hormonal balance